Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Brian K. Martin"'
Autor:
Igor Morozov, Thomas P. Monath, David A. Meekins, Jessie D. Trujillo, Sun-Young Sunwoo, Kinga Urbaniak, In Joong Kim, Sanjeev K. Narayanan, Sabarish V. Indran, Wenjun Ma, William C. Wilson, Cassandra O'Connor, Sheri Dubey, Sean P. Troth, Beth-Ann Coller, Richard Nichols, Brian K. Martin, Heinz Feldmann, Juergen A. Richt
Publikováno v:
Emerging Microbes and Infections, Vol 10, Iss 1, Pp 651-663 (2021)
The recent impact of Ebola virus disease (EVD) on public health in Africa clearly demonstrates the need for a safe and efficacious vaccine to control outbreaks and mitigate its threat to global health. ERVEBO® is an effective recombinant Vesicular S
Externí odkaz:
https://doaj.org/article/76a36bca1a3948bfb5561339b098a75b
Autor:
Thomas P. Monath, Patricia E. Fast, Kayvon Modjarrad, David K. Clarke, Brian K. Martin, Joan Fusco, Richard Nichols, D. Gray Heppner, Jakub K. Simon, Sheri Dubey, Sean P. Troth, Jayanthi Wolf, Vidisha Singh, Beth-Ann Coller, James S. Robertson
Publikováno v:
Vaccine: X, Vol 1, Iss , Pp - (2019)
The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) was formed to evaluate the safety and characteristics of live, recombinant viral vector vaccines. A recent publication by the V3SWG described live, attenuated, recombinant
Externí odkaz:
https://doaj.org/article/b07b8cb0eee148b0870ad44a4db1f958
Autor:
Sean P. Troth, Heinz Feldmann, Sabarish V. Indran, Sheri Dubey, Sanjeev Narayanan, Juergen A. Richt, Wenjun Ma, Cassandra O'Connor, Jessie D. Trujillo, Richard A. Nichols, Brian K. Martin, Sun Young Sunwoo, Beth-Ann Coller, William C. Wilson, Igor Morozov, Thomas P. Monath, In-Joong Kim, Kinga Urbaniak, David A. Meekins
Publikováno v:
Emerging Microbes & Infections
article-version (VoR) Version of Record
article-version (VoR) Version of Record
The recent impact of Ebola virus disease (EVD) on public health in Africa clearly demonstrates the need for a safe and efficacious vaccine to control outbreaks and mitigate its threat to global health. ERVEBO® is an effective recombinant Vesicular S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e23b3d63e410bbd76c8dfb9759754c6e
Autor:
Meng Shi, Jay W. Hooper, Nelson L. Michael, Shon Remich, James E. Moon, Judie B. Alimonti, Nicole M. Van Deusen, Paula Muñoz, Jocelyn Voell, Richard T. Davey, Barney S. Graham, Peter Silvera, Zonghui Hu, Linda L. Jagodzinski, H. Clifford Lane, Ramiro L. Gutierrez, Yan Zhou, Matthew D. Josleyn, Amy R. Castellano, John H. Beigel, Steven A. Kwilas, Patrick S. Twomey, Daphne A. Stanley, Kirsten S. Smith, Charles J. Link, Brian K. Martin, Kristopher M. Paolino, Wang Jing, W. Jay Ramsey, Holly R. Hack, Jason W. Bennett, Jason A. Regules, Olivier Tshiani Mbaya, Richard C. Ruck, Sheila A. Peel, Stephen J. Thomas, Nancy J. Sullivan, Julie E. Ledgerwood, Thomas P. Monath, Meagan L. Wisniewski
Publikováno v:
New England Journal of Medicine. 376:330-341
The worst Ebola virus disease (EVD) outbreak in history has resulted in more than 28,000 cases and 11,000 deaths. We present the final results of two phase 1 trials of an attenuated, replication-competent, recombinant vesicular stomatitis virus (rVSV
Autor:
Richard A. Nichols, Chester McDowell, Thomas P. Monath, Jürgen A. Richt, Brian K. Martin, Igor Morozov, Steven Ellsworth, Vinay Shivanna, Jessie D. Trujillo, A. Sally Davis, Emily J Dasen
Publikováno v:
The Journal of general virology. 100(11)
Vesicular stomatitis (VS) is a notifiable disease of livestock affecting cattle, horses, pigs and humans. Vesicular stomatitis virus (VSV) serotypes Indiana and New Jersey are endemic to Central America; however, they also cause sporadic and scattere
Autor:
Zhi Jin Xu, Rick Nichols, M Adams, R Das, WJ Ramsey, Tracy Kemp, TL Kemp, Thomas P. Monath, EA Sheldon, Brian K. Martin, R Bliss, J Saleh, Charles J. Link, EJ Dasen, Joan Fusco, R Klein, RA Feldman, Eric Gerstenberger, Laurence Chu, WB Smith, Richard A. Nichols, Eric A Sheldon, ZJ Xu, Brandon Essink, J Creager, Teresa Nowak, Joseph D. Crowell, D. Gray Heppner, Emily J Dasen, JL Borders, WM Seger, Rituparna Das, William Jay Ramsey, Tomasz Nowak, Donald Gray Heppner
Publikováno v:
The Lancet. Infectious diseases. 17(8)
Summary Background The 2014 Zaire Ebola virus outbreak highlighted the need for a safe, effective vaccine with a rapid onset of protection. We report the safety and immunogenicity of the recombinant vesicular stomatitis virus-Zaire Ebola virus envelo
Publikováno v:
Molecular Immunology. 48:219-230
Demyelination in the central nervous system (CNS) is known to involve several immune effector mechanisms, including complement proteins. Local production of complement by glial cells in the brain can be both harmful and protective. To investigate the
Publikováno v:
Glia. 55:1405-1415
Complement has been implicated as a potential effector mechanism in neurodegeneration; yet the precise role of complement in this process remains elusive. In this report, we have utilized the cuprizone model of demyelination-remyelination to examine
Autor:
Brian K. Martin
Publikováno v:
Immunologic Research. 39:146-159
Immune complement is a critical system in the immune response and protection of host cells from damage by complement is critical during inflammation. The expression of the receptors for the inflammatory anaphylatoxin molecules is also key in immunity
Autor:
Brian K. Martin, Carol B. Martin
Publikováno v:
The Journal of Immunology. 175:3123-3132
The complement anaphylatoxins, C3a and C5a, exert their effects by binding to their respective receptors. A number of studies have implicated these proteins in human disease, yet little is known about anaphylatoxin receptor gene regulation. In this r